Moderna
MRNA
#1630
Rank
โ‚ฌ8.85 B
Marketcap
22,91ย โ‚ฌ
Share price
-2.41%
Change (1 day)
-75.73%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

Market capitalization of Moderna (MRNA)

Market cap: โ‚ฌ8.85 Billion

As of April 2025 Moderna has a market cap of โ‚ฌ8.85 Billion. This makes Moderna the world's 1630th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Moderna from 2018 to 2025

End of year Market Cap

Year Marketcap Change
2025โ‚ฌ8.85 B-40.33%
2024โ‚ฌ14.84 B-56.74%
2023โ‚ฌ34.30 B-46.68%
2022โ‚ฌ64.33 B-29.25%
2021โ‚ฌ90.92 B170.54%
2020โ‚ฌ33.60 B471.97%
2019โ‚ฌ5.87 B33.89%
2018โ‚ฌ4.38 B

End of Day market cap according to different sources

On Apr 3rd, 2025 the market cap of Moderna was reported to be:

โ‚ฌ9.05 Billion
by Nasdaq info icon info icon
โ‚ฌ9.07 Billion
by CompaniesMarketCap info icon info icon
โ‚ฌ9.07 Billion
by Yahoo Finance info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
โ‚ฌ0.10 B-98.85%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ187.72 B 2,019.84%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ0.76 M-99.99%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ27.83 B 214.29%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ190.70 B 2,053.49%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
โ‚ฌ1.33 B-84.89%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ336.86 B 3,703.89%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ2.71 B-69.33%๐Ÿ‡บ๐Ÿ‡ธ USA